HOME >> BIOLOGY >> NEWS
New proteomics research promises to revolutionize biomedical discovery

Montral, July 19 2007 Human cells function through the concerted action of thousands of proteins that control their growth and differentiation. Yet, the specific function of most human proteins remains either unknown or poorly characterized. Diseases being often due to aberrations in the function of key cellular proteins, numerous large-scale research initiatives have been launched internationally to crack the function of all human proteins. In a research article that will be published in the July 20th issue of the journal Molecular Cell, a research team led by Dr. Benoit Coulombe from the Institut de recherches cliniques de Montral (IRCM) describes a powerful proteomics approach that promises to have a profound impact on our current understanding of the human proteome and the function of its individual proteins.

In this work, we have taken advantage of an intrinsic property of proteins in order to develop a method that we use to infer a putative function to many previously uncharacterized proteins, said Dr. Coulombe who is very excited by his teams achievement and the future prospects these efforts hold. The unique property of proteins, exploited by this Montreal research team, is the fact that proteins rarely work alone, but rather assemble with other proteins into complexes to concertedly exert their function. The strategy of the IRCM researchers was basically to identify the interaction partners of many proteins of well-known function, using sophisticated proteomics procedures and computational algorithms they developed. The initial guess of the scientists was that proteins interacting together are likely to be partners in the same biological pathway and, consequently, to serve the same (or related) function(s). By systematically identifying the interaction partners of 32 human proteins known to exert specific functions in gene transcription and RNA processing, the Coulombe team has defined an intricate network of 805 high-confidence interactions
'"/>

Contact: Lucette Thriault
lucette.theriault@ircm.qc.ca
514-987-5535
Institut de recherches cliniques de Montreal
19-Jul-2007


Page: 1 2 3

Related biology news :

1. Lab-on-a-chip device from Berkeley Lab to speed proteomics research
2. Role for proteomics in identifying hematologic malignancies
3. An infectious agent of deception, exposed through proteomics
4. NIST and NCI to collaborate on proteomics assessment
5. Advanced genomics and proteomics improve the diagnosis and treatment of a deadly lung disease
6. New Columbia University center aims to advance next generation of genomics, proteomics research
7. Premature births from inflammation and infection rapidly detected by proteomics technology
8. Searle grant funds proteomics initiative
9. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
10. Saudi Arabias KAUST names WHOI first research partner
11. Multinational research: protecting ecology means understanding people, too

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2017)... ALLENTOWN, Pa. , March 20, 2017 ... PD 2.0 personal spirometer and Wellness Management System (WMS), ... Founded in 2010, PMD Healthcare is a ... Company with a mission dedicated to creating innovative solutions ... of life. With that intent focus, PMD developed the ...
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, 2017 /PRNewswire/ ... 23andMe , the leading personal genetics company, are ... can now provide customers with personalized nutrition plans that ... biometrics, but also genetic markers impacting how their body ... personalized food decision support platform uses biometrics such as ...
(Date:3/2/2017)... -- Summary This report provides all the information ... and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... , March 22, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage ... drug delivery systems, announced today that Dr. ... deliver a presentation titled, "Oral Insulin for Diabetes ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
(Date:3/22/2017)... 2017   VWR (NASDAQ: VWR), ... and service solutions to laboratory and production ... EPL Archives, Inc., an international biorepository services ... regulated product research, development and commercialization lifecycle ... ancillary services. EPL Archives is widely recognized ...
Breaking Biology Technology:
Cached News: